Statin therapy after stroke or transient ischemic attack [1]

New England Journal of Medicine

Volumn 355, Issue 22, 2006, Pages 2368-

  Cohen, Jay S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; LIVER ENZYME; PLACEBO; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; AMINOTRANSFERASE; HEPTANOIC ACID DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRROLE DERIVATIVE;

CLINICAL TRIAL; DOSE RESPONSE; DRUG MEGADOSE; ENZYME METABOLISM; HUMAN; LETTER; LIVER TOXICITY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; DRUG EFFECT; DRUG SAFETY; RISK ASSESSMENT; TREATMENT OUTCOME; BLOOD; BRAIN HEMORRHAGE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; NOTE; SURVIVAL;

CARDIOVASCULAR DISEASES; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL, LDL; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRROLES; RISK FACTORS; TRANSAMINASES; MORTALITY; SURVIVAL ANALYSIS;

EID: 33751534785     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc062456     Document Type: Letter

References (4)

1. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.
2. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35.
3. Kent DM. Stroke - an equal opportunity for the initiation of statin therapy. N Engl J Med 2006;355:613-5.
4. Pitt B. Low-density lipoprotein cholesterol in patients with stable coronary heart disease - is it time to shift our goals? N Engl J Med 2005;352:1483-4.